Daily Archives: March 17, 2021
Five-year outcomes of PFO closure or antiplatelet therapy for cryptogenic stroke
17 Mar, 2021 | 02:40h | UTCPFO Closure for Stroke Is Safe, Effective at 5 Years: REDUCE – TCTMD
Original study: Five-Year Outcomes of PFO Closure or Antiplatelet Therapy for Cryptogenic Stroke – New England Journal of Medicine ($)
USPSTF Draft Statement: Start screening for Prediabetes and Type 2 Diabetes Mellitus in adults ages 35 to 70 years who are overweight or obese
17 Mar, 2021 | 02:41h | UTCCommentary: USPSTF Lowers Age for Diabetes Screening in Draft Recommendation – NEJM Journal Watch
UC secures landmark open access deal with world’s largest scientific publisher
17 Mar, 2021 | 02:33h | UTC
Commentary on Twitter
Good to see that the University of California and Elsevier has reached an agreement in which "all research with a UC lead author published in Elsevier’s extensive portfolio of hybrid and open access journals will be #openaccess by default"
— Robert Kiley (@robertkiley) March 16, 2021
RCT: No benefit from marine Omega-3 fatty acid and Vitamin D supplementation on incident atrial fibrillation
17 Mar, 2021 | 02:38h | UTCEffect of Marine Omega-3 Fatty Acid and Vitamin D Supplementation on Incident Atrial Fibrillation: A Randomized Clinical Trial – JAMA (free for a limited period)
Editorial: Omega-3 Fatty Acids and Atrial Fibrillation – JAMA (free for a limited period)
Opinion | Cardiovascular harm from egg yolk and meat: More than just cholesterol and saturated fat
17 Mar, 2021 | 02:35h | UTC
Systematic review | Hospital at home: home‐based end‐of‐life care
17 Mar, 2021 | 02:31h | UTCHospital at home: home‐based end‐of‐life care – Cochrane Library
Summary: Home-based end-of-life care – Cochrane Library
Consensus Document: Management of acute myocarditis and chronic inflammatory cardiomyopathy
17 Mar, 2021 | 02:28h | UTC
Systematic review: Interventions for cutaneous disease in systemic lupus erythematosus
17 Mar, 2021 | 02:30h | UTCInterventions for cutaneous disease in systemic lupus erythematosus – Cochrane Library
Podcast | Abdominal pain: Physical exam series
17 Mar, 2021 | 02:25h | UTC#261, #262 Abdominal Pain: Physical Exam Series – The Curbsiders Internal Medicine Podcast
A randomized, noninferiority, controlled trial of two doses of intravenous subdissociative ketamine for analgesia in the emergency department
17 Mar, 2021 | 02:13h | UTCA randomized, noninferiority, controlled trial of two doses of intravenous subdissociative ketamine for analgesia in the emergency department – Academic Emergency Medicine (link to abstract – $ for full-text)
Commentaries: Lower dose of ketamine is as effective as the standard dose to treat pain in adults – Loyola University Health System AND Lower doses of ketamine shown to be non-inferior for acute pain control in the emergency setting – 2 Minute Medicine
M-A: Time to reconsider the routine use of tourniquets in total knee arthroplasty surgery
17 Mar, 2021 | 02:23h | UTC
[Preprint] Delaying second vaccine dose leaves cancer patients vulnerable to virus
17 Mar, 2021 | 02:58h | UTCNews release: Delaying second vaccine dose leaves cancer patients vulnerable to virus – King’s College London
Commentaries: Expert reaction to preprint looking at antibody immune response following one dose of Pfizer COVID-19 vaccine in cancer patients – Science Media Centre AND Cancer patients ‘lack same protection’ after first jab – BBC
WHO points to wildlife farms in southern China as likely source of pandemic
17 Mar, 2021 | 03:02h | UTCWHO Points To Wildlife Farms In Southern China As Likely Source Of Pandemic – wbur
WHO: New research highlights risks of separating newborns from mothers during COVID-19 pandemic
17 Mar, 2021 | 03:04h | UTC
Immunogenicity of a single dose of SARS-CoV-2 mRNA vaccine in solid organ transplant recipients
17 Mar, 2021 | 02:55h | UTC
RCT: Oxford/AstraZeneca vaccine does not protect against mild-to-moderate Covid-19 due to the B.1.351 variant
17 Mar, 2021 | 03:01h | UTCCommentaries: AstraZeneca vaccine doesn’t prevent B1351 COVID in early trial – CIDRAP AND Oxford/AstraZeneca Fails to Prevent Mild to Moderate Covid-19 From B.1.351 (“South Africa”) Variant – Brief19
FDA: Why you should not use Ivermectin to treat or prevent COVID-19
17 Mar, 2021 | 02:51h | UTCWhy You Should Not Use Ivermectin to Treat or Prevent COVID-19 – U.S. Food & Drug Administration
Commentary: FDA Rejects Ivermectin, Despite Growing Interest In Some Corners Of The Internet – Brief19
Related: RCT: Ivermectin does not improve time to resolution of symptoms among adults with mild COVID-19
COVID‐19 and its cardiovascular effects: a systematic review of prevalence studies
17 Mar, 2021 | 02:52h | UTC
Commentary on Twitter
How common are pre‐existing heart & blood vessel problems in #COVID19? What are most common complications affecting heart & blood vessels in #COVID19? @CochraneHeart review of prevalence studies: https://t.co/rDqz2GyrpH
— The Cochrane Library (@CochraneLibrary) March 12, 2021
Imaging review of peripheral nerve injuries in patients with COVID-19
17 Mar, 2021 | 02:48h | UTCImaging Review of Peripheral Nerve Injuries in Patients with COVID-19 – Radiology
‘Then the world caved in’: 11 experts describe the day they realized Covid-19 was here to stay
17 Mar, 2021 | 02:49h | UTC
COVID antibody treatments show promise for preventing severe disease
17 Mar, 2021 | 02:46h | UTCCOVID antibody treatments show promise for preventing severe disease – Nature
Consensus Statement on Analgo-sedation in Neurocritical Care and Review of Literature
17 Mar, 2021 | 02:09h | UTC